Hypertension: Harrison's & Saseen Flashcards
Most contemporary guidelines endorse what kind of blood pressure goals for most patients?
< 140/90
Most contemporary guidelines endorse what kind of blood pressure goals for patients with diabetes or chronic kidney disease?
< 130/80
Some controversy exists about certain groups of patients & blood pressure goals? What patient groups?
Patients with CAD, vascular disease (stroke, PAD), & those with a 10 year risk of CAD
What should the clinician’s first consideration be in selecting anti-hypertensive drug therapy?
Is there a compelling indication for a SPECIFIC drug therapy?
What are some comorbidities that create compelling indications for specific anti-hypertensive drugs?
#Diabetes #Chronic kidney disease #Coronary artery disease #Left ventricular dysfunction #Previous ischemic stroke
First line regimen for patients with DIABETES?
Add-on therapy?
1st line: ACE-inhibitor or ARB
Add-on: Thiazide, then beta-blocker &/or CCB
First line regimen for patients with CHRONIC KIDNEY DISEASE:
ACE-inhibitor or ARB
First line regimen for patients with CORONARY ARTERY DISEASE?
Add-on therapy?
1st line: beta-blocker & ACE-inhibitor or ARB
Add-on: Aldosterone antagonist, CCB, and/or thiazide diuretic
First line regimen for patients with LEFT VENTRICULAR DYSFUNCTION?
Add-on therapy?
1st line: Diuretic, ACE-inhibitor or ARB, & Beta-blocker
Add-on: Aldosterone antagonist &/or hydralazine with isosorbide dinitrate
First line regimen for patients with PREVIOUS ISCHEMIC STROKE:
#ACE-inhibitor with or without #Thiazide diuretic
True or false: most diabetics with hypertension can be controlled on a single drug.
False. Most require 2-3 drugs to attain control.
Why are ACE or ARBs recommended as 1st line therapy for diabetics with hypertension?
Both have been proven to reduce the risk of CV events & kidney disease progression in diabetic patients.
Why are calcium-channel blockers particularly useful in diabetics with hypertension?
They do not affect glycemic control.
How does estimated glomerular filtration rate affect the selection of diuretic in a hypertensive diabetic patient?
eGFR > 30: thiazide diuretic
eGFR < 30: loop diuretic
What is the thiazide diuretic used in clinical trials regarding hypertensive diabetic patients?
Chlorthalidone
Beta-blockers are considered 3rd or 4th line add-on for diabetic patients with hypertension. Why?
Risk of hyperglycemia with beta-blocker therapy
True or false: all beta-blockers carry the same risk for hyperglycemia in diabetic patients.
False: in the GEMINI trial, carvedilol had no significant effect on glucose, but metoprolol did.
How does the clinician identify CKD in a hypertensive patient for the purposes of drug therapy?
CKD in Stage 3 or higher:
1) eGFR < 60 (serum creatinine > 1.3 in women or 1.5 in men)
2) Albuminuria > 300 mg/day
Diuretics can serve 2 purposes in the hypertensive CKD patient. What are they?
1) BP control
2) volume regulation
When should the clinician choose a thiazide diuretic for a CKD patient? A loop diuretic?
Thiazide: eGFR > 30
Loop: eGFR < 30, or patient in volume overload/edema
Why are beta-blockers the cornerstone of anti-hypertension therapy in patients with CAD?
Proven long term benefits: reduces risk of death by more than 20%. Effects: #reduces stimulation of myocardium #balances myocardium oxygen supply vs. demand #treats ischemic symptoms
How does an ACE or ARB benefit the hypertensive CAD patient?
Preventing adverse cardiac remodeling
In addition to the first line of beta-blocker & ACE/ARB, how can a CCB benefit a hypertensive CAD patient?
Treat ischemic symptoms
When should the clinician select a dihydropyridine CCB vs. a non-dihydropyridine CCB?
If added to beta-blocker, select the DIHYDROPYRIDINE CCB (to avoid excessive bradycardia). If beta-blocker is contraindicated, select the NON-DIHYDROPYRIDINE CCB, because of ability to lower heart rate & reduce myocardial oxygen demand (i.e. what the beta-blocker WOULD be doing if they could take it).
In addition to lower BP, diuretic therapy has what other purpose in the patient with hypertension & LV dysfunction?
Treating or preventing fluid overload
Use of beta-blockers in addition to ACE/ARB for patients with LV dysfunction has an additional benefit. What is it?
Increased ejection fraction
What rule should the clinician remember when starting beta-blocker therapy on a hypertensive patient with LV dysfunction?
Start low, go slow!
[Start at a low dose & titrate up to a target dose.]
For African-American patients in particular, what 3rd or 4th line therapy has been shown to reduce CV events in hypertensive patients with LV dysfunction?
Hydralazine in combo with isosorbide dinitrate
History of a CVA, especially ischemic, is a compelling indication for use of…
a diuretic!
Certain drug combinations have been shown in trials to reduce risk of recurrent stroke, MI, & CV events in patients with prior stroke. What are they?
#Diuretics alone #Diuretics in combination with ACE-inhibitors
True or false: ARB therapy has been shown to reduce risk of recurrent stroke in hypertensive patients.
False. It has not been shown to reduce CVA risk either as first or second line therapy.
How do ACE-inhibitors work?
By inhibiting ACE, resulting in decreased angiotensin II. This causes decreased vasoconstriction, decreased aldosterone secretion, & sodium/water retention.
How do ARBs work?
Blockade of angiotensin II type 1 receptor. Decreases the effects of angiotensin II, causing decreased vasoconstriction, decreased aldosterone secretion, & sodium/water retention.
How do CCBs: Dihydropyridines work?
Blocking cellular calcium entry through L-type channel. Results in reduced total peripheral resistance through arterial vasodilation.
How do CCBs: Non-dihydropyridines work?
Blocking cellular calcium entry through L-type channel. Results in reduced total peripheral resistance through arterial vasodilation. ADDITIONALLY: decreased myocardial contractility results in negative inotropic effect, blocked AV nodal conduction results in decreased HR.